In connection with the implementation of the project entitled “Development and introduction to the market of the first non-antibiotic product for the treatment of infectious eye diseases with an innovative ophthalmological composition in the form of eye drops, containing an active substance – povidone iodine” funded by the state budget from the Agency for Medical Research, Polpharma Pharmaceutical Works S.A, is requesting bids for to conduct a non-clinical study of pharmacodynamics and safety after repeated administration in an animal model of adaptive bacterial eye infection.
Details of the price inquiry can be found in the documents attached below.